ENGN
enGene Holdings Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.82
−0.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.48x
- Price / sales
- —
- Price / cash flow
- -1.11x
Enterprise value
- Enterprise value
- -$103.2M
- EV / sales
- —
- EV / EBITDA
- 0.82x
- EV / EBIT
- 1.50x
- Market cap
- $121.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Apr 1, 2026